ARBITEL

This brand name is authorized in Nigeria.

Active ingredients

The drug ARBITEL contains one active pharmaceutical ingredient (API):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5988	Tablet	Arbitel 40 Tablets TAB 40 mg 3 x 10's (in Alu-Alu blisters)	Tablets. White to off-white coloured, oval shaped, biconvex uncoated tablets with T 40 engraved on one side and plain on the other side	21/12/2023
A4-5989	Tablet	Arbitel 80 Tablets TAB 80 mg 3 x 10's (in Alu-Alu blisters)	Tablets. White to off-white coloured, capsule shaped, biconvex uncoated tablets with T8O engraved on one side and plain on the other side	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA07	Telmisartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5988, A4-5989